Greek National Top 40 under 40 - Founder Profile: Prof. Dr. S Tsakas II

Prof. Dr. S Tsakas II is a world renowned entrepreneur with over two decades of experience. He is also an Adjunct Professor at Babson College and completing his PhD from the University of Edinburgh.
 
Prof. Dr. S Tsakas II
Prof. Dr. S Tsakas II
ASTORIA, N.Y. - July 27, 2016 - PRLog -- Prof. Dr. S Tsakas II, also known as Ross, and Founder of SVS Medical (www.svsmedical.com) as well as STFIH Group (www.stfih.com), is profiled in this interview with the Greek national press following his nomination as the top candidate in the "National Top 40 under 40" award. He is an accomplished serial entrepreneur with seven multinational businesses in various stages of development and has innovated some of the breakthrough technologies in global health for the 21st century. In addition, he is fluent in multiple languages and currently completing his PhD in Science, Technology and Innovation Studies from the University of Edinburgh.

When asked about his successes in the professional sector:

"I believe no one is a success much like nothing is a success. Today a person is famous and tomorrow they are in court for something. Products are breakthrough and then replaced. Companies become Goliaths that then fail to Davids. In my opinion, success is much like beauty; it is a constantly evolving attribute. You can succeed financially and still be unhappy. You can also give back and end up with nothing, as I have many times in the past. My goal daily is to optimize my time through applying useful innovation to improve daily life."

Some quotes about Prof. Dr. S Tsakas II by world renowned business professionals and organizations:

Forbes, Editor in Chief Randall Lane:

"Ross Tsakas checks a lot of the aforementioned boxes. The Scotsman is an impressive presenter with a huge, game-changing idea – a one-vial delivery system for vaccines that has applications worldwide, especially in the developing world. The Gates Foundation has spent billions creating efficient ways to deliver vaccines to poor nations. As Tsakas presented, one could only wonder what the Gates team would say about his technology. Then he showed his cards: The Gates Foundation had already given him a grant to support his research. Tsakas wound up with a $500,000 investment and the runner-up designation.

Bloomberg BusinessWeek Profile:

"Mr. Spyridon Tsakas, also known as Ross, founded Eulysis UK Limited in 2010 and serves as its Managing Director. Mr. Tsakas is an innovative, multi-award winning entrepreneur with international business experience. He is sponsored by the Bill & Melinda Gates Foundation, Royal Society of Edinburgh, Prince's Trust and Scottish Enterprise. He serves as an Executive Director of Eulysis. He also lectures at the Massachusetts Institute of Technology, Tufts University and the University of Edinburgh, on topics including Entrepreneurship and Healthcare, International Business, Macroeconomics and Healthcare Finance."

Ross is presently launching and leading SVS Medical LLC to expand pharmaceutical access globally through the platform Single Vial System "SVS" technology which has been endorsed by the World Health Organization, UNICEF, Doctors Without Borders, Program for Appropriate Technology in Health and also funded by the Bill & Melinda Gates Foundation, Royal Society of Edinburgh, Scottish Enterprise and the Prince's Trust.

He is actively seeking new contacts across all industries to expedite the market launch and impact of this philanthropic yet commercially lucrative opportunity worldwide.

Contact
Prof. Dr. S Tsakas II
rt@svsmedical.com
9783337117

Photo:
https://www.prlog.org/12575924/1
End
Source: » Follow
Email:***@svsmedical.com Email Verified
Tags:Entrepreneurship, Innovation, Business Magnates
Industry:Biotech
Location:Astoria - New York - United States
Account Email Address Verified     Account Phone Number Verified     Disclaimer     Report Abuse



Like PRLog?
9K2K1K
Click to Share